Inventor
MCDOWELL ROBERT S
US30 patents
⚠️ This page may combine multiple inventors who share the name “MCDOWELL ROBERT S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
11 patentsUS5532359AJul 2, 1996
Ras farnesyl transferase inhibitors
GENENTECH INC192 citations97
US6271198B1Aug 7, 2001
Constrained helical peptides and methods of making same
GENENTECH INC103 citations96
US5493007AFeb 20, 1996
Platelet aggregation inhibitors having high specificity for GPIIBIIIA
GENENTECH INC64 citations96
US5846932ADec 8, 1998
Receptor specific atrial natriuretic peptides
GENENTECH INC79 citations95
US5798337AAug 25, 1998
Low molecular weight peptidomimetic growth hormone secretagogues
GENENTECH INC70 citations95
US6525022B1Feb 25, 2003
Receptor specific atrial natriuretic peptides
GENENTECH INC35 citations92
US5665704ASep 9, 1997
Receptor specific atrial natriuretic peptides
GENENTECH INC56 citations92
US5843941ADec 1, 1998
Ras farnesyl transferase inhibitors
GENENTECH INC48 citations91
US6034216AMar 7, 2000
Low molecular weight peptidomimetic growth hormone secretagogues
GENENTECH INC12 citations73
US7094869B2Aug 22, 2006
Low molecular weight peptidomimetic growth hormone secretagogues
GENENTECH INC4 citations62
US5756452AMay 26, 1998
Platelet aggregation inhibitors having high specificity for GP IIb IIIa
GENENTECH INC2 citations62
AVENTIS PHARMA SA
4 patentsUS6344439B1Feb 5, 2002
Agents for promoting bone formation
AVENTIS PHARMA SA6 citations73
US6339082B1Jan 15, 2002
Tricyclic compounds, preparation method and said method intermediates, application as medicines and pharmaceutical compositions containing same
AVENTIS PHARMA SA3 citations62
US6277845B1Aug 21, 2001
Hydrazono-benzazulene derivatives, pharmaceutical compositions and intermediates
AVENTIS PHARMA SA1 citations52
US6459001B1Oct 1, 2002
Tricyclic compounds, their preparation process and the intermediates of this process, their use as medicaments and the pharmaceutical compositions containing them
AVENTIS PHARMA SA0 citations41
3 V BIOSCIENCES INC
4 patentsUS10118913B2Nov 6, 2018
Heterocyclic modulators of lipid synthesis
3 V BIOSCIENCES INC4 citations72
US10053450B2Aug 21, 2018
Heterocyclic modulators of lipid synthesis
3 V BIOSCIENCES INC3 citations72
US10189822B2Jan 29, 2019
Heterocyclic modulators of lipid synthesis
3 V BIOSCIENCES INC4 citations70
US10226449B2Mar 12, 2019
Heterocyclic modulators of lipid synthesis and combinations thereof
3 V BIOSCIENCES INC0 citations39
3-V BIOSCIENCES INC
3 patentsSAGIMET BIOSCIENCES INC
3 patentsUS11034690B2Jun 15, 2021
Heterocyclic modulators of lipid synthesis
SAGIMET BIOSCIENCES INC2 citations70
US11622968B2Apr 11, 2023
Heterocyclic modulators of lipid synthesis
SAGIMET BIOSCIENCES INC2 citations69
US12551490B2Feb 17, 2026
Heterocyclic modulators of lipid synthesis
SAGIMET BIOSCIENCES INC0 citations59
SUNESIS PHARMACEUTICALS INC
2 patentsUS6806279B2Oct 19, 2004
Small-molecule inhibitors of interleukin-2
SUNESIS PHARMACEUTICALS INC23 citations89
US7214487B2May 8, 2007
Methods for identifying compounds that modulate enzymatic activities by employing covalently bonded target-extender complexes with ligand candidates
SUNESIS PHARMACEUTICALS INC5 citations61
HOECHST MARION ROUSSEL INC
2 patentsUS6221907B1Apr 24, 2001
Tricyclic compounds having activity specific for integrins, particularly alphanubeta3 integrins, method for preparing same, intermediates therefor, use of said compounds as drugs, and pharmaceutical compositions containing same
HOECHST MARION ROUSSEL INC16 citations83
US6194380B1Feb 27, 2001
Agents for promoting bone formation
HOECHST MARION ROUSSEL INC5 citations62